Ardelyx Inc (ARDX)

Currency in USD
6.880
+0.550(+8.69%)
Closed·
6.920+0.040(+0.57%)
·
Unusual trading volume
ARDX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6.0007.060
52 wk Range
3.2108.400
Key Statistics
Prev. Close
6.33
Open
6
Day's Range
6-7.06
52 wk Range
3.21-8.4
Volume
11.63M
Average Volume (3m)
3.76M
1-Year Change
66.586%
Book Value / Share
0.61
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ARDX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
16.444
Upside
+139.02%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Ardelyx Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

10 Buy
0 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 16.444
(+139.02% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Leerink Partners
Buy17.00+147.09%-Maintain12-03-2026
Piper Sandler
Buy16.00+132.56%-Maintain23-02-2026
H.C. Wainwright
Buy18.00+161.63%10.00Maintain20-02-2026
Raymond James
Buy19.00+176.16%-Maintain03-02-2026
TD Cowen
Buy13.00+88.95%10.00Maintain29-01-2026

Ardelyx Inc Earnings Call Summary for Q1/2026

  • Ardelyx reported Q1 2026 net loss of $37.6M ($0.15/share), missing EPS forecast of -$0.1263; revenue of $93.4M fell short of $96.36M estimate.
  • Total product revenue surged 38% YoY; IBSRELA sales jumped 58%, driving growth despite operational efficiency challenges and rising expenses.
  • Company provided 2026 revenue guidance of $410M-$430M (50-57% YoY growth); targets $1B annual revenue by 2029 amid profitability transition.
  • Stock rose 0.83% to $6.06 in aftermarket trading; analysts forecast 2026 profitability with $0.03 EPS and price targets ranging $13-$19.
  • R&D expenses increased 35.6% to $20.2M; SG&A rose 22.9% to $102.3M, raising margin pressure concerns despite improved net loss performance.
Last Updated: 01-05-2026, 03:04 am
Read Full Transcript

Earnings

Latest Release
30-04-2026
EPS / Forecast
-0.15 / -0.13
Revenue / Forecast
94.47M / 96.36M
EPS Revisions
Last 90 days

ARDX Income Statement

Compare ARDX to Peers and Sector

Metrics to compare
ARDX
Peers
Sector
Relationship
P/E Ratio
−29.3x−3.2x−0.5x
PEG Ratio
5.60−0.050.00
Price/Book
11.4x1.6x2.6x
Price / LTM Sales
4.0x8.8x3.2x
Upside (Analyst Target)
147.1%97.3%48.1%
Fair Value Upside
Unlock24.1%6.6%Unlock

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
69.46M28.32%477.87M
Other Institutional Investors
121.95M49.73%839.01M
Public Companies & Retail Investors
53.84M21.95%370.42M
Total
245.25M100.00%1.69B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.8.62%2,11,39,1051,45,437
The Vanguard Group, Inc.7.74%1,89,79,4831,30,579

FAQ

What Is the Ardelyx Inc (ARDX) Share Price Today?

The Ardelyx Inc share price today is 6.880.

What is the current Ardelyx Inc (ARDX) share price and day range?

As of 03-05-2026, the Ardelyx Inc share price is 6.880, with a previous close of 6.330. The share price has ranged from 6.000 to 7.060 today, while the 52-week range spans from 3.210 to 8.400.

What Is the Ardelyx Inc Market Cap?

As of today, Ardelyx Inc market cap is 1.700B.

What Is the Ardelyx Inc (ARDX) Share Price Target?

The average 12-month share price target for Ardelyx Inc is 16.444, with a high estimate of 19 and a low estimate of 13. 10 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +139.02% Upside potential.

What Is Ardelyx Inc's Earnings Per Share (TTM)?

The Ardelyx Inc EPS (TTM) is -0.239.

When Is the Next Ardelyx Inc Earnings Date?

Ardelyx Inc will release its next earnings report on 30-07-2026.

From a Technical Analysis Perspective, Is ARDX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

What Stock Exchange Does Ardelyx Inc Trade On?

Ardelyx Inc is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Ardelyx Inc?

The stock symbol for Ardelyx Inc is "ARDX."

How Many Times Has Ardelyx Inc Stock Split?

Ardelyx Inc has split 0 times.

How Many Employees Does Ardelyx Inc Have?

Ardelyx Inc has 489 employees.

What Is the ARDX Premarket Price?

ARDX's last pre-market stock price is 6.150. The pre-market share volume is 35,360.000, and the stock has changed by -0.180, or -2.840%.

What Is the ARDX After Hours Price?

ARDX's last after hours stock price is 6.920, the stock has changed by 0.040, or 0.570%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.